Print this page    •   Back to Web version of article

Failure of Combination Abacavir + Tenofovir + Lamivudine (3TC)

July 25, 2003

In late July 2003 GlaxoSmithKline warned physicians that a three-drug combination of lamivudine (Epivir®), abacavir (Ziagen®) and tenofovir (VireadTM) had failed to control HIV effectively in about half the treatment-naive patients in a clinical trial. The cause of the reduced response to this particular regimen is not known, but it may involve mutations causing cross-resistance to the drugs; Glaxo is also checking for chemical interactions inside the cell. The problem is not due to any one of the drugs; rather, for some reason this particular combination turned out not to work well.

The company advised:

"Abacavir and lamivudine in combination with tenofovir should not be used as a triple antiretroviral therapy when considering a new treatment regimen for naive or pre-treated patients;

"Any patient currently controlled on therapy with this combination should be closely monitored and considered for modification of therapy; and

"Any usage of this triple combination with other antiretroviral agents should be closely monitored for signs of treatment failure."


ISSN # 1052-4207

Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.


Back to the AIDS Treatment News July 25, 2003 contents page.




This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art31752.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.